Evidence map›Paper›PMID 33791841›Full record

ArticlePediatric radiology2021

Pulmonary imaging in coronavirus disease 2019 (COVID-19): a series of 140 Latin American children.

Carlos F Ugas-Charcape, María Elena Ucar, Judith Almanza-Aranda, Emiliana Rizo-Patrón, Claudia Lazarte-Rantes, Pablo Caro-Domínguez, Lina Cadavid, Lizbet Pérez-Marrero, Tatiana Fazecas, Lucía Gomez and 8 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Pediatric radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 15 institutions in 12 countries.

Carlos F Ugas-CharcapeDepartment of Diagnostic Imaging, Instituto Nacional de Salud del Niño San Borja, Av. Javier Prado Este 3101, 15037, Lima, Peru. cugas@insnsb.gob.pe.ORCID 0000-0002-8380-3276
María Elena UcarServicio de Diagnóstico por Imágenes, Hospital de Niños Sor María Ludovica, La Plata, Argentina.
Judith Almanza-ArandaServicio de Imagenología, Salud Digna, Ciudad de México, Mexico.
Emiliana Rizo-PatrónUnidad de Desarrollo de Investigación, Tecnologías y Docencia, Instituto Nacional de Salud del Niño San Borja, Lima, Peru.
Claudia Lazarte-RantesDepartment of Diagnostic Imaging, Instituto Nacional de Salud del Niño San Borja, Av. Javier Prado Este 3101, 15037, Lima, Peru.
Pablo Caro-DomínguezUnidad de Radiología Pediátrica, Servicio de Radiología, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Lina CadavidRadiology Department, Hospital Pablo Tobón Uribe - IMEDI, Medellín, Colombia.
Lizbet Pérez-MarreroDepartamento de Imágenes, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago de Chile, Chile.
Tatiana FazecasDepartment of Diagnostic Imaging, Hospital Municipal Jesus, Alta Excelência Diagnóstica/DASA, Clínica de Diagnóstico por Imagem/DASA, Rio de Janeiro, Brazil.
Lucía GomezServicio de Imagen, Hospital Pediátrico Baca Ortiz, Quito, Ecuador.
Mariana Sánchez CurielDepartment of Diagnostic Imaging, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
Walter PachecoServicio de Radiología e Imágenes Médicas, Hospital María Especialidades Pediátricas, Tegucigalpa, Honduras.
Ana RizziDepartamento de Diagnóstico por Imágenes, Hospital de Pediatria Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.
Andrés García-BayceDepartment of Imaging, Centro Hospitalario Pereira Rossell, Montevideo, Uruguay.
Efigenia BendeckDepartamento de Radiología e Imágenes, Hospital Nacional de Niños "Benjamin Bloom,", San Salvador, El Salvador.
Mario MontañoServicio de Diagnóstico por Imágenes, Hospital Santa Cruz C.P.S., Santa Cruz de la Sierra, Bolivia.
Pedro DaltroAlta Excelência Diagnóstica/DASA and Clínica de Diagnóstico por Imagem/DASA, Rio de Janeiro, Brazil.
José D Arce-VServicio de Radiología e Imágenes, Clínica Santa María, Santiago, Chile.
Instituto Nacional de Salud del Niño · PECentrus Diagnósticos por Imagem · BRCentro Hospitalario Pereira Rossell · UYClinica Santa Maria · CLGarrahan Hospital · ARHospital de Niños Superiora Sor María Ludovica · ARHospital Infantil de México Federico Gómez · MXHospital Nacional de Niños Bloom · SVHospital Pablo Tobon Uribe · COHospital Universitario Virgen del Rocío · ESPediatric Hospital "Baca Ortiz" · ECSecretaria de Salud · MXUniversidad del Desarrollo · CLUniversidad Metropolitana de Honduras · HNUniversidad Privada de Santa Cruz de la Sierra · BO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which resulted in the worldwide coronavirus disease 2019 (COVID-19) pandemic of 2020, has particularly affected Latin America.

objectiveThe purpose of the study was to analyze the imaging findings of pulmonary COVID-19 in a large pediatric series. MATERIALS AND

methodsChildren with SARS-CoV-2 infection confirmed by either quantitative reverse transcription-polymerase chain reaction from nasopharyngeal swabs or presence of circulating immunoglobulin M (IgM) antibodies and who underwent chest radiograph or CT or both were included in this retrospective multicenter study. Three pediatric radiologists independently reviewed radiographs and CTs to identify the presence, localization, distribution and extension of pulmonary lesions.

resultsWe included 140 children (71 female; median age 6.3 years, interquartile range 1.6-12.1 years) in the study. Peribronchial thickening (93%), ground-glass opacities (79%) and vascular engorgement (63%) were the most frequent findings on 131 radiographs. Ground-glass opacities (91%), vascular engorgement (84%) and peribronchial thickening (72%) were the most frequent findings on 32 CTs. Peribronchial thickening (100%), ground-glass opacities (83%) and pulmonary vascular engorgement (79%) were common radiograph findings in asymptomatic children (n=25). Ground-glass opacity and consolidation were significantly higher in children who needed intensive care admission or died (92% and 48%), in contrast with children with a favorable outcome (71% and 24%, respectively; P<0.05).

conclusionAsymptomatic children and those with mild symptoms of COVID-19 showed mainly peribronchial thickening, ground-glass opacities and pulmonary vascular engorgement on radiographs. Ground-glass opacity and consolidation were more common in children who required intensive care admission or died.

Indexed as

AdultChildChild, PreschoolCOVID-19COVID-19 Nucleic Acid TestingFemaleHumansInfantLatin AmericaLungMaleMexicoRetrospective StudiesSARS-CoV-2Tomography, X-Ray ComputedChestChildrenComputed tomographyCoronavirus disease 2019LungsPulmonaryRadiographySevere acute respiratory syndrome coronavirus 2

Identifiers

PMID33791841
PMCPMC8012415
OpenAlexW3110329676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.